Latest Prescription Drugs news
Women Have Worse Outcomes Than Men With Beta-Blockers After Acute MI
posted September 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
β-Blockers Not Beneficial After MI Without Reduced Left Ventricular Ejection Fraction
posted September 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Subcutaneous Leqembi for Treatment of Early Alzheimer Disease
posted September 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Now Providing Daily Updates on Adverse Events
posted August 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors .jpg)
Recommendations Updated for Management of Anemia in CKD 
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus 
Therapies Compared for Newly Diagnosed Multiple Sclerosis Related Articles
Initial Rx Length Tied to Long-Term Use of Z-Drugs 
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML 
Updated Recommendations Address Medications to Prevent Migraine in Adults 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders Monthly Specialist Briefings
Stay Connected
